Novocure(NVCR.US)

Last Updated 19:00:00 ET
longbridge loading

NovoCure (NVCR) Is Up 9.7% After Raising 2026 Revenue Outlook And Posting Stronger Q1 Sales

Simplywall·
US
NVCR
+1.72%
US
BIB
+0.08%
US
FBT
+0.74%
Simplywall·
US
NVCR
+1.72%
US
BIB
+0.08%
US
FBT
+0.74%

3 Overlooked Stocks Set to Soar in 2026

nasdaq·
US
MBX
+0.54%
US
NVCR
+1.72%
US
AXSM
+1.00%
nasdaq·
US
MBX
+0.54%
US
NVCR
+1.72%
US
AXSM
+1.00%

Stocks with rising relative price strength: Novocure

MSN·
US
NVCR
+1.72%
US
SBIO
+1.66%
US
LABU
+2.52%
MSN·
US
NVCR
+1.72%
US
SBIO
+1.66%
US
LABU
+2.52%

NovoCure’s Optune Pax Win And TRIDENT Data Shape Growth Outlook

Simplywall·
US
NVCR
+1.72%
US
XBI
+0.87%
US
LABU
+2.52%
Simplywall·
US
NVCR
+1.72%
US
XBI
+0.87%
US
LABU
+2.52%

NovoCure shares are trading higher after the company reported better-than-expected Q1 sales results and raised its FY26 sales guidance with its midpoint above estimates.

benzinga_article·
US
NVCR
+1.72%
US
XHE
+0.28%
US
IHI
-0.51%
benzinga_article·
US
NVCR
+1.72%
US
XHE
+0.28%
US
IHI
-0.51%

NovoCure Reports Q1 2026 Results: Full Earnings Call Transcript

benzinga_article·
US
NVCR
+1.72%
benzinga_article·
US
NVCR
+1.72%

Novocure | 8-K: FY2026 Q1 Revenue Beats Estimate at USD 174.06 M

Earnings Watch·
US
NVCR
+1.72%
Earnings Watch·
US
NVCR
+1.72%

NovoCure Q1 2026 earnings preview

MSN·
US
NVCR
+1.72%
US
BIB
+0.08%
US
FBT
+0.74%
MSN·
US
NVCR
+1.72%
US
BIB
+0.08%
US
FBT
+0.74%
© 2026 Longbridge｜Disclaimer